CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 143 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,503,000 | +2.9% | 134,001 | -1.4% | 0.00% | 0.0% |
| Q1 2019 | $1,461,000 | -26.1% | 135,871 | +3.8% | 0.00% | -33.3% |
| Q4 2018 | $1,976,000 | +84.2% | 130,849 | +125.7% | 0.01% | +100.0% |
| Q3 2018 | $1,073,000 | -10.5% | 57,977 | +10.5% | 0.00% | 0.0% |
| Q2 2018 | $1,199,000 | -21.7% | 52,450 | -2.6% | 0.00% | -25.0% |
| Q1 2018 | $1,532,000 | +153.6% | 53,861 | +88.3% | 0.00% | +100.0% |
| Q4 2017 | $604,000 | – | 28,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,803,700 | $25,130,000 | 0.91% |
| Altium Capital Management LP | 663,800 | $2,874,000 | 0.79% |
| Rubric Capital Management LP | 2,406,449 | $10,420,000 | 0.49% |
| RTW INVESTMENTS, LP | 6,029,700 | $26,109,000 | 0.38% |
| Orbimed Advisors | 3,214,509 | $13,919,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 152,345 | $660,000 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 980,085 | $4,244,000 | 0.12% |
| Point72 Asset Management, L.P. | 6,303,025 | $27,292,000 | 0.11% |
| Sender Co & Partners, Inc. | 40,720 | $176,000 | 0.09% |
| Manteio Capital LLC | 15,067 | $65,000 | 0.08% |